Inici › Leucèmia › Pennsilvània › Philadelphia
Assaigs clínics de Leucèmia a Philadelphia, PA
12 estudis de Leucèmia busquen participants en centres de Philadelphia i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ReclutantEstudi observacional
- Children's Hospital of Philadelphia, Philadelphia
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ReclutantFase 1/2
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
ReclutantFase 1
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ReclutantFase 3
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutantFase 2
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
ReclutantEstudi observacional
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
ReclutantFase 1
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
ReclutantEstudi observacional
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
ReclutantFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutantFase 1
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
ReclutantFase 1 inicial
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Philadelphia
Assaigs de Leucèmia en altres ciutats
- Houston, TX28 estudis
- Boston, MA25 estudis
- New York City, NY19 estudis
- Los Angeles, CA16 estudis
- Chicago, IL16 estudis
- Durham, NC13 estudis
- Baldwin Park, CA12 estudis
- Columbus, OH12 estudis
- Nashville, TN12 estudis
- Milwaukee, WI11 estudis
- Atlanta, GA11 estudis
- Seattle, WA11 estudis
Altres estudis a Philadelphia
- Càncer (tots els tipus)59 estudis
- Càncer de mama56 estudis
- Càncer de pulmó de cèl·lules no petites51 estudis
- Càncer metastàtic46 estudis
- Càncer colorrectal44 estudis
- Càncer d'ovari44 estudis
- Càncer de pròstata44 estudis
- Càncer de pulmó36 estudis
- Leucèmia mieloide aguda34 estudis
- Insuficiència cardíaca31 estudis
- Càncer d'endometri28 estudis
- Depressió26 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.